Cetera Advisor Networks’s Can-Fite BioPharma American Depositary Shares CANF Stock Holding History

Cetera Advisor Networks’s Portfolio CANF Stock Details CANF Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q1	–	Sell	-654	Closed	-$169K	–	2082
2021 Q4	$169K	Hold	654	–	–	﹤0.01%	1907
2021 Q3	$217K	Sell	654 -133	-17%	-$52.3K	﹤0.01%	1748
2021 Q2	$359K	Sell	787 -13	-2%	-$5.7K	0.01%	1379
2021 Q1	$395K	Buy	+800	New	+$347K	0.01%	986

Other funds holding CANF

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fifth Third Bancorp Cincinnati, Ohio $54.7B AUM 26.51% 1-Year Est. Return

Stifel Financial St. Louis, Missouri $109B AUM 21.36% 1-Year Est. Return

Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Citigroup New York $235B AUM 32.99% 1-Year Est. Return

National Bank of Canada Montreal, Quebec, Canada $112B AUM 31.26% 1-Year Est. Return

CAPTRUST Financial Advisors Raleigh, North Carolina $57.3B AUM 18.32% 1-Year Est. Return

Wells Fargo San Francisco, California $530B AUM 22.01% 1-Year Est. Return

APA

American Portfolios Advisors Holbrook, New York $2.36B AUM 14.59% 1-Year Est. Return

Cetera Advisor Networks's CANF Position: Q1 2022 in Review

Cetera Advisor Networks sold out of Can-Fite BioPharma American Depositary Shares (CANF) in Q1 2022, closing a stake of 654 shares — an estimated $169K sold.

Cetera Advisor Networks first reported a position in CANF in Q1 2021 and held it in 4 quarters. The position peaked at $395K in Q1 2021. 13 funds tracked by Wall St. Rank hold CANF as of Q1 2022.

Cetera Advisor Networks reported no remaining Can-Fite BioPharma American Depositary Shares position as of Q1 2022 after selling out during the quarter.
Cetera Advisor Networks sold 654 Can-Fite BioPharma American Depositary Shares shares in Q1 2022, an estimated $169K.
Cetera Advisor Networks first reported a position in Can-Fite BioPharma American Depositary Shares in Q1 2021 and held it in 4 quarters.
Cetera Advisor Networks's Can-Fite BioPharma American Depositary Shares position peaked at $395K in Q1 2021.
13 funds tracked by Wall St. Rank held Can-Fite BioPharma American Depositary Shares as of Q1 2022.

Based on Cetera Advisor Networks's 13F filing for Q1 2022, filed 12 May 2022.